LOC440982: A Potential Drug Target for Cancer and IDH1-Positive Cancer

LOC440982: A Potential Drug Target for Cancer and IDH1-Positive Cancer

LOC440982 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA 440982, and it is characterized by its unique structure and its ability to interact with various cellular components.

One of the most interesting aspects of LOC440982 is its ability to interact with the protein p21, which is a well-known regulator of the cell cycle. LOC440982 has been shown to physically interact with p21, and this interaction has been used to study the effects of p21 on LOC440982 expression and function.

In addition to its interaction with p21, LOC440982 has also been shown to play a role in the regulation of cell proliferation. It has been shown to inhibit the activity of the protein kinase inhibitor p53, which is known for its ability to prevent cell growth and division.

These findings suggest that LOC440982 may be a drug target or biomarker for the treatment of various diseases, including cancer. By interacting with p21 and inhibiting the activity of p53, LOC440982 may be able to disrupt the regulation of cell growth and division, which could lead to the inhibition of the growth and spread of cancer cells.

LOC440982 has also been shown to interact with the protein IDH1, which is a gene that is mutated in many types of cancer. IDH1 is known for its ability to cause cancer cells to grow and divide uncontrollably, and LOC440982 has been shown to interact with IDH1 to regulate its activity.

These findings suggest that LOC440982 may be a useful biomarker for the diagnosis and treatment ofIDH1-positive cancer. By interacting with IDH1 and regulating its activity, LOC440982 may be able to contribute to the development of new treatments for this aggressive form of cancer.

LOC440982 has also been shown to interact with the protein TCF7L1, which is a gene that is involved in the regulation of cell adhesion. TCF7L1 is known for its ability to control the movement of cells along the surface of the body, and LOC440982 has been shown to interact with TCF7L1 to regulate its activity.

These findings suggest that LOC440982 may be a useful biomarker for the diagnosis and treatment of diseases that are characterized by the disruption of cell adhesion, such as cancer. By interacting with TCF7L1 and regulating its activity, LOC440982 may be able to contribute to the development of new treatments for these diseases.

In conclusion, LOC440982 is a protein that has been shown to interact with various cellular components and to play a role in the regulation of cell growth and division. These findings suggest that LOC440982 may be a drug target or biomarker for the treatment of various diseases, including cancer andIDH1-positive cancer. Further research is needed to fully understand the role of LOC440982 in these diseases and to develop new treatments based on these findings.

Protein Name: Uncharacterized LOC440982

The "LOC440982 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC440982 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC441052 | LOC441081 | LOC441087 | LOC441179 | LOC441228 | LOC441239 | LOC441455 | LOC441666 | LOC441722 | LOC441956 | LOC442028 | LOC442497 | LOC497256 | LOC541473 | LOC550113 | LOC553139 | LOC554206 | LOC574080 | LOC606724 | LOC613266 | LOC642131 | LOC642361 | LOC642422 | LOC642502 | LOC642590 | LOC642677 | LOC642730 | LOC642846 | LOC642947 | LOC643201 | LOC643339 | LOC643406 | LOC643441 | LOC643454 | LOC643763 | LOC643855 | LOC643923 | LOC644006 | LOC644083 | LOC644086 | LOC644189 | LOC644215 | LOC644277 | LOC644525 | LOC644584 | LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739